CSP exam test questions with correct
answers
,PDC calculation - CORRECT ANSPDC = (# of unique days with supply / number of days in a period) x 100
Which medication is a Jak inhibitor?
a. Humira (adalimumab)
b. Orencia (abatacept)
c. Actemra (toclizumab)
d. Xeljanz (tofacitinib) - CORRECT ANSd. Xeljanz (tofacitinib)
Which medication can elevate cholesterol?
a. Actemra (toclizumab)
b. Enbrel (etanercept)
c. Simponi (golimumab)
d. Kineret (anakinra) - CORRECT ANSa. Actemra (toclizumab)
Which shingles vaccine is safe to administer with TNF inhibitors?
a. Adacel
b. Zostavax
c. Shingrix
d. Varivax - CORRECT ANSc. Shingrix
Most biologics increase the risk of infections, which of the following also increases the risk of
neutropenia?
a. Rituxin (rituximab)
b. Taltz (ixekizumab)
c. Remicade (infliximab)
, d. Cimzia (certolizumab pegol) - CORRECT ANSb. Taltz (ixekizumab)
Which psoriasis medication does not require screening for tuberculosis?
a. Stelara (ustekinumab)
b. Otezla (apremilast)
c. Cocentyx (seculinumab)
d. Humira (adalimumab) - CORRECT ANSb. Otezla (apremilast)
What is the standard starting dose for Taltz (ixekizumab) when used to treat psoriatic arthritis?
a. 160mg subcutaneously once, followed by 80mg subcutaneously at weeks 2, 4, 6, 8, 10
and 12; then 80mg subcutaneously every 4 weeks
b. 160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks
c. 160mg subcutaneously once, followed by 80mg subcutaneously every week for 4 weeks,
then 80mg every 4 weeks
d. 160mg subcutaneously once, followed by 80mg subcutaneously every other week - CORRECT ANSb.
160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks
A 45 y/o, 200lb patient is struggling with severe dermatitis and the provider wants to potentially
start a biologic. Which medication would you recommend?
a. Protopic (tacrolimus)
b. Humira (adalimumab)
c. Stelara (ustekinumab)
d. Dupixent (dupilumab) - CORRECT ANSd. Dupixent (dupilumab)
A 56 y/o, 140lb patient with psoriasis will be starting Stelara (ustekinumab), but the provider
wants to verify the dosing of the medication. What starting dose would you recommend?
answers
,PDC calculation - CORRECT ANSPDC = (# of unique days with supply / number of days in a period) x 100
Which medication is a Jak inhibitor?
a. Humira (adalimumab)
b. Orencia (abatacept)
c. Actemra (toclizumab)
d. Xeljanz (tofacitinib) - CORRECT ANSd. Xeljanz (tofacitinib)
Which medication can elevate cholesterol?
a. Actemra (toclizumab)
b. Enbrel (etanercept)
c. Simponi (golimumab)
d. Kineret (anakinra) - CORRECT ANSa. Actemra (toclizumab)
Which shingles vaccine is safe to administer with TNF inhibitors?
a. Adacel
b. Zostavax
c. Shingrix
d. Varivax - CORRECT ANSc. Shingrix
Most biologics increase the risk of infections, which of the following also increases the risk of
neutropenia?
a. Rituxin (rituximab)
b. Taltz (ixekizumab)
c. Remicade (infliximab)
, d. Cimzia (certolizumab pegol) - CORRECT ANSb. Taltz (ixekizumab)
Which psoriasis medication does not require screening for tuberculosis?
a. Stelara (ustekinumab)
b. Otezla (apremilast)
c. Cocentyx (seculinumab)
d. Humira (adalimumab) - CORRECT ANSb. Otezla (apremilast)
What is the standard starting dose for Taltz (ixekizumab) when used to treat psoriatic arthritis?
a. 160mg subcutaneously once, followed by 80mg subcutaneously at weeks 2, 4, 6, 8, 10
and 12; then 80mg subcutaneously every 4 weeks
b. 160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks
c. 160mg subcutaneously once, followed by 80mg subcutaneously every week for 4 weeks,
then 80mg every 4 weeks
d. 160mg subcutaneously once, followed by 80mg subcutaneously every other week - CORRECT ANSb.
160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks
A 45 y/o, 200lb patient is struggling with severe dermatitis and the provider wants to potentially
start a biologic. Which medication would you recommend?
a. Protopic (tacrolimus)
b. Humira (adalimumab)
c. Stelara (ustekinumab)
d. Dupixent (dupilumab) - CORRECT ANSd. Dupixent (dupilumab)
A 56 y/o, 140lb patient with psoriasis will be starting Stelara (ustekinumab), but the provider
wants to verify the dosing of the medication. What starting dose would you recommend?
